Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 3 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Recs

0
Player Avatar leebest1a (< 20) Submitted: 8/1/2010 3:51:11 PM : Outperform Start Price: $3.40 VICL Score: -34.13

VICL

Featured Broker Partners


Advertisement